Skip to main content
BCPC logo

Balchem Corp (BCPC) Stock: Price, Forecast & Analyst Target

Balchem Corp (BCPC) — MoonshotScore 89/100 (Exceptional band), calculated Nov 18, 2026. Price $168.73 (-0.53%), as of the Nov 18, 2026 trading session; market cap $5.36B. Expected results Feb 19, 2027.

Educational signal · not a buy or sell recommendation · How to read this

$168.73 −$0.90 (-0.53%) Market Cap $5.36B

Balchem Corp · BCPC · NASDAQ · Basic Materials · Chemicals - Specialty

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.

Price as of Nov 18, 2026

Key Statistics

89 of 100

MoonshotScore v2 · Balchem (BCPC)

Exceptional
Business Quality Elite (85)
Financial Safety Fortress (95)
Valuation Rich (28)
Growth Durability Compounding (83)
Momentum Surging (84)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality, a fortress balance sheet and durable growth, but an expensive valuation; the market is already moving on it. Business Quality: Elite; Financial Safety: Fortress; Valuation: Rich; Growth Durability: Compounding; Momentum: Surging.

Enterprise value relative to EBITDA is the main valuation drag relative to sector peers.

  • EPS beat 0 of the last 4 reports
  • Altman Z 10.87 · Piotroski F 8
  • ROE 13.0% · ROA 8.5% · current ratio 2.47

Holding back: a rich price

Helping: business quality, balance-sheet strength, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for BCPC (57 recorded, newest six shown)
RecordedScoreBand
86Exceptional
86Exceptional
85Exceptional
85Exceptional
89Exceptional
89Exceptional

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$168.73
Change on the day-0.53%
52-week range$147.18–$186.15
Market capitalisation$5.36B—
Price / earnings (trailing)31.77
Shares traded on the day208.9K
Beta (volatility vs the S&P 500)0.85

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Oct 17, 2025 to Nov 18, 2026: low $148, high $181, latest $169. 4 reported quarters marked, 3 above and 1 below the recorded estimate. $181 $148 high $181 Feb 20, 2026 · Earnings results · reported above the recorded estimate · close $1711Apr 30, 2026 · Earnings results · reported below the recorded estimate · close $1622Jul 31, 2026 · Earnings results · reported above the recorded estimate · close $1683Oct 23, 2026 · Earnings results · reported above the recorded estimate · close $1774 Oct 17, 2025 Nov 18, 2026 · $169 $148Oct 17, 2025$153Oct 31, 2025$157Nov 14, 2025$156Nov 28, 2025$156Dec 12, 2025$157Dec 26, 2025$160Jan 9, 2026$168Jan 23, 2026$173Feb 6, 2026$171Feb 20, 2026$175Mar 6, 2026$162Mar 20, 2026$170Apr 2, 2026$178Apr 17, 2026$162May 1, 2026$159May 15, 2026$157May 29, 2026$165Jun 12, 2026$171Jun 26, 2026$162Jul 10, 2026$163Jul 24, 2026$179Aug 7, 2026$181Aug 21, 2026$172Sep 4, 2026$167Sep 18, 2026$167Oct 2, 2026$171Oct 16, 2026$170Oct 30, 2026$173Nov 13, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · above the recorded estimate
  • · Earnings results · below the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate
How to read these dates

Estimated dates can change.

What to watch next

Other perspectives

Council score for Balchem (BCPC): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Strong
Financial Safety Strong
Valuation Weak
Growth Durability Strong
Momentum Strong

Legends Council

4 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Griffin-style lens (simulated) Ken Griffin Neutral read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Neutral read

Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Moderate
Debt/Equity Moderate
ROE Moderate
Gross Margin Neutral

Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Nov 17, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Balchem (BCPC), and what does it report?

Short answer

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. Balchem Corp (BCPC) is listed on NASDAQ. Basic Materials / Chemicals Specialty SEC filing business address: Montvale, NJ. It employs 1,430 people and is led by Theodore L. Harris. The market values it at $5.36B.

2 · Latest results

What do the latest results show for Balchem (BCPC)?

Short answer · as of

Against analyst estimates the company has EPS beat 0 of the last 4 reports.

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Period endRevenueR&DSG&AFMP standardized operating result
Sep 30, 2026Not availableNot availableNot availableNot available
Mar 31, 2026Not availableNot availableNot availableNot available
Dec 31, 2025Not availableNot availableNot availableNot available
Sep 30, 2025Not availableNot availableNot availableNot available
How to read these figures

Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$290.66M Oct 23, 2026
Latest report · revenue estimate
$289.25M Oct 23, 2026
Latest report · revenue vs estimate
Above estimate Oct 23, 2026
Latest report · EPS vs estimate
Above estimate Oct 23, 2026
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Oct 23, 2026$290.66M$289.25M$1.5700$1.4300
Jul 31, 2026$284.00M$268.50M$1.4000$1.2700
Apr 30, 2026$270.71M$266.50M$1.2500$1.3300
Feb 20, 2026$263.62M$259.59M$1.3100$1.2900
How to read these figures

Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Jun 2025$255M$38M—
Sep 2025$268M$40M$1.24 (diluted)
Q4 FY2025$264M$39M$1.21 (diluted)
Q1 FY2026$271M$40M$1.25 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Balchem (BCPC)?

Short answer

Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway. The MoonshotScore pillars rate business quality, balance-sheet strength, durable growth, positive momentum as strengths. What is holding it back is a rich price. The distress and quality screens read Altman Z 10.87 · Piotroski F 8. Trailing ratios: ROE 13.0% · ROA 8.5% · current ratio 2.47.

Data-derived red flags

  • Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 4 reported quarters.
  • Rich valuation — a P/E of 31.77 runs well above the Basic Materials sector’s ~19.90x, leaving little room for a miss.
4 · What to check next?

What should you watch next at Balchem (BCPC)?

Short answer · as of

The next earnings report is expected on Feb 19, 2027. Current published price targets run low $210.00 · high $215.00 · consensus $212.50 · median $212.50 against a quoted price of $168.73 (as of Nov 18, 2026).

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Balchem compare with its peers?

Short answer

Balchem's score ranks 4th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
SSR Mining Inc. (SSRM) Named competitor$24.19 Nov 18, 2026$4.83B98 5-pillar Nov 18, 2026
WD-40 Company (WDFC) Same industry, near in market value$222.03 Nov 18, 2026$2.97B93 5-pillar Nov 18, 2026
Sasol Limited (SSL) Named competitor$12.09 Nov 18, 2026$7.75B91 5-pillar Nov 18, 2026
Balchem (BCPC) — this page$168.73$5.36B89
NewMarket Corporation (NEU) Same industry, near in market value$703.23 Nov 18, 2026$6.47B80 5-pillar Nov 18, 2026
Hawkins, Inc. (HWKN) Same industry, near in market value$153.20 Nov 18, 2026$3.19B76 5-pillar Nov 18, 2026
Axalta Coating Systems Ltd. (AXTA) Named competitor$36.46 Nov 18, 2026$7.80B69 5-pillar Nov 18, 2026
Cabot Corporation (CBT) Same industry, near in market value$74.03 Nov 18, 2026$3.80B66 5-pillar Nov 18, 2026
Eldorado Gold Corporation (EGO) Named competitor$28.38 Nov 18, 2026$7.41B65 5-pillar Nov 18, 2026
Sensient Technologies Corporation (SXT) Same industry, near in market value$117.59 Nov 18, 2026$5.00B65 5-pillar Nov 18, 2026
Ashland Inc. (ASH) Same industry, near in market value$76.39 Nov 18, 2026$3.50B65 5-pillar Nov 18, 2026
Avient Corporation (AVNT) Same industry, near in market value$44.34 Nov 18, 2026$4.07B64 5-pillar Nov 18, 2026
Eastman Chemical Company (EMN) Same industry, near in market value$62.36 Nov 18, 2026$7.13B63 5-pillar Nov 18, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Basic Materials stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$210.00 – $215.00
Consensus target
$212.50
Median target
$212.50

Consensus record · Captured .

Measured against a quoted price of $168.73 (as of Nov 18, 2026).

Insider activity

Form 4 records via FMP · Most recent available transactions

Transactions
12
Identified insiders
8
Purchases
0
Sales
0
Other transactions
12

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held BCPC in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported BCPC in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Balchem (BCPC)?

Read these with our analysis →

Common Questions About BCPC (Basic Materials)

These answers are editorial: 1 of these 9 answers is drawn from the BCPC research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for BCPC?

BCPC carries the MoonshotScore stated above — the Exceptional band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Is BCPC a good stock to buy?

Stock Expert AI does not rate BCPC buy, sell or hold. Balchem Corp carries a MoonshotScore, in the Exceptional band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the BCPC stock price today?

The last price recorded for Balchem Corp (BCPC), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the BCPC price target?

The analyst consensus price target for Balchem Corp (BCPC), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What do analysts say about BCPC stock?

Analyst coverage of Balchem Corporation (BCPC) typically focuses on its growth prospects, profitability, and competitive positioning within the specialty chemicals industry. Key valuation metrics include the P/E ratio, profit margin, and gross margin.

What are the key factors to evaluate for BCPC?

Balchem Corp (BCPC) holds a MoonshotScore in the high range. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. Strategic Acquisitions and Partnerships: Balchem can pursue strategic acquisitions and partnerships to expand its product portfolio and geographic reach. Not financial advice.

How frequently does BCPC data refresh on this page?

BCPC's price is the last quote we recorded, from the Nov 18, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven BCPC's recent stock price performance?

Balchem Corp (BCPC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider BCPC overvalued or undervalued right now?

The trailing P/E of Balchem Corp (BCPC) is listed under Price & valuation, and the analyst consensus target under Analyst targets & estimates, on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 47 figures on this page — 1 from SEC filings and earnings calls, 39 from Financial Modeling Prep (FMP), 3 with no recorded source, 2 computed by us, formula shown in the register and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.